Although 25 G sutureless vitrectomy has increased in popularity, it is associated with postoperative complications including hypotony, choroidal detachment, and endophthalmitis. Richard Kaiser, MD, from the Retina Service of Wills Eye Institute, Philadelphia, noted that the 25 G procedure has a 12.4 times greater risk of endophthalmitis when compared with the 20 G procedure.
Three-year results from the Tube versus Trabeculectomy Study showed that tube-shunt surgery was more likely than trabeculectomy with mitomycin C to maintain IOP control and avoid persistent hypotony, loss of light perception vision, or re-operation for glaucoma.
Until I see research to convince me otherwise, steroid therapy will continue to be my drug of choice.
We should not be adding another drug to the therapeutic mix without having established the efficacy and side effect profile of a single therapy.
Despite the higher rate of prevalence in women, it is men who are more likely to suffer severe vision loss as a result of idiopathic intracranial hypertension (IIH), according to study results published online ahead of print by Neurology.
25 G surgery offers enhanced patient comfort as well as faster postoperative recovery.
There are those who say that blue or violet light actually benefits the eye. If this is true, we must have evolved really badly.
Administering fixed combinations as first-line treatment allows us to understand quickly whether our patients are non-responders or insufficient responders.
All the latest news and industry developments in focus, December 2008
Problems with night vision correlate to an increase in the risk of symptoms of both the wet and dry forms of age-related macular degeneration (AMD), according to study results published in the November issue of Ophthalmology.
Links to other useful ophthalmology resources on the web
Optical coherence tomography (OCT) is valuable in managing diabetic macular oedema (DME), more so than fluorescein angiography, in which the degree of leakage is not correlated with visual acuity and outcomes, according to Peter Kaiser, MD.
The most recent featured discussion on the European Ophthalmology forum was on the topic of patient numbers
Claiming that blue light is harmful and should be blocked is nothing more than a marketing ploy backed by absurd arguments.
There is no evidence to suggest that there is rapid glaucoma progression following refractive surgery.
An antioxidant eye drop (OT-551, Othera) is being investigated to treat geographic atrophy in dry age-related macular degeneration (AMD).
Professor Gerd U. Auffarth petitions the European Parliament for the introduction of co-pay schemes for cataract patients in the EU
Novagali Pharma SA has withdrawn the EMEA centralized marketing authorization application for Vekacia (cyclosporin) 0.05% eye drops, which had been intended for the treatment of vernal keratoconjunctivitis (VKC).
OTE's Victoria Farrell interviews Cambodian paediatric ophthalmologist Phara Khauv to find out how an ORBIS initiative has impacted his practice in a vastly underserved country.
Whether the stromal flap is thin or thick is irrelevant; it will never heal fully.
The high incidence of side effects associated with steroids makes them a less favourable treatment option.
A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc.
The difficulty of accurate IOL power calculation in postLASIK eyes is an issue being faced increasingly by cataract surgeons. Jack T. Holladay, MD, clinical professor of ophthalmology, Baylor College of Medicine, Houston, Texas, US offered several tips for achieving better refractive outcomes in this growing population of eyes.
Long-term use of anti-vascular endothelial growth factor (VEGF) drugs should be treated with caution because endogenous VEGF plays an important role in the maintenance of retina neuronal cells, according to study results published by PLoS ONE on the 3rd November.
The slimmer design of 25 G instruments has left us exposed to an increased risk of complications and decreased surgical control.
The Phase I three-year feasibility study of the Argus II Retinal Implant for Retinitis Pigmentosa (RP) will be expanded to enrol more patients in Europe, according to an announcement from Second Sight Medical Products, the implant's manufacturer.
Although there is a relatively high rate of diabetic retinopathy (DR) progressing to proliferative diabetic retinopathy (PDR), the level of PDR care available has improved, according to 25-year results of the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), published in the November issue of Ophthalmology.
It may be possible to regenerate optic neural axons by manipulating growth control pathways, according to study results published in the 7 November issue of the journal Science.
GS-101, Gene Signal's experimental topical ophthalmic solution designed to prevent the rejection of corneal grafts, has entered Phase III trials.
Instead of combined surgery, cataract extraction alone by phacoemulsification through a clear corneal incision with posterior chamber IOL implantation may be the most appropriate procedure for patients with controlled or modestly uncontrolled glaucoma as well as for patients with ocular hypertension or glaucoma suspects.